Total Funding
44
3
Total FundingGrant raised
Growth Score
-4 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
484742
Ubiquigent provides the research community with reagents, kits, and drug discovery, assay development and compound profiling services.
- Jason Mundin: Chief Executive Officer
- Sheelagh Frame: Chief Scientific Officer
About the Company
Ubiquigent Limited is a specialist developer and supplier of high quality reagents, kits and drug discovery assay development and compound profiling services to the life science research community worldwide.
Ubiquigent's scientific and business interests have a clear focus; namely the ubiquitin, ubiquitin-like and integrated signalling
systems.
The company has established its scientific and business credentials with both academic researchers undertaking fundamental scientific discovery as well as with pharmaceutical and biotechnology company scientists exploring the potential of ubiquitin cascade-focused drug discovery.
